Mankind Pharma, India’s fourth-largest pharmaceutical company, has completed a multi-year transformation of its global supply chain and strategic procurement functions. Through this large-scale initiative, the company has strengthened medicine availability, improved supply reliability, and built a scalable foundation for disciplined growth.
Delivered in collaboration with Accenture, the transformation embeds digitally enabled operating models powered by advanced analytics and AI across procurement, manufacturing, and distribution networks. As a result, Mankind Pharma can now manage demand volatility, supply disruptions, and regulatory complexities with greater speed and precision.
Building an Integrated, End-to-End Operating Backbone
To begin with, Mankind Pharma unified two critical operating pillars—global supply chain and strategic sourcing—into a single, integrated backbone. This new framework tightly links planning intelligence with execution performance.
As per the press release, the company reimagined its supply chain through an integrated planning platform that connects demand forecasting, manufacturing, inventory management, and distribution within a near real-time decision-making environment. Notably, this system operates across more than 25 international markets. Powered by advanced analytics and AI-augmented insights, the platform has significantly strengthened forecast accuracy, improved cross-functional collaboration, and enabled faster, more responsive planning.
At the same time, Mankind Pharma undertook an 18-month overhaul of its sourcing and procurement function. The company standardized processes, strengthened governance, enhanced supplier collaboration, and introduced digital automation alongside analytics-led decision-making.
Measurable Impact Across Global Operations
Importantly, the transformation has delivered clear and measurable outcomes. The customized planning and execution platform now spans 30 manufacturing facilities and over 50 distribution centers worldwide.
Consequently, the company reduced drug stock-outs by 75 percent and optimized inventory levels by up to 20 percent across its global distribution network. In addition, the platform has enhanced decision-making and improved coordination among commercial, manufacturing, and supply teams. Together, these improvements have strengthened supply chain performance at scale while maintaining high standards of quality and regulatory compliance.
Elevating Procurement as a Strategic Capability
Alongside supply chain modernization, Mankind Pharma repositioned procurement as a core business capability. The company clarified sourcing ownership and standardized end-to-end processes to improve both efficiency and governance.
Digital tools now automate routine operational tasks, enabling procurement teams to focus on strategic sourcing decisions and long-term supplier partnerships. Meanwhile, advanced analytics provide leadership with deeper visibility into spending patterns, supplier performance, and potential supply chain risks. As a result, the company has achieved sustainable cost efficiencies without compromising quality, compliance, or supply continuity.
Leadership Perspectives on the Transformation
Arjun Juneja, Chief Operating Officer, Mankind Pharma Ltd., emphasized the strategic importance of the initiative.
“Ensuring uninterrupted access to quality medicines today requires value chains that are intelligent, digitally enabled, and resilient by design. At Mankind, we have reimagined the traditional value chain into a life chain—built to serve patients, not just processes. By integrating demand, procurement, manufacturing, inventory management, and execution through advanced analytics and AI-augmented insights, we have strengthened our ability to anticipate demand, manage volatility, and respond with speed and precision across markets. This transformation goes beyond efficiency. It delivers sharper visibility, stronger control, and quality and compliance by design. It also enables us to scale responsibly and sustainably while reinforcing our commitment to Availability, Quality, and Affordability.”
Jignesh Vora, Managing Director and Lead – Life Sciences, Accenture in India, added,
“Working closely with Mankind Pharma, we helped reimagine and strengthen the company’s operating model for the long term. By combining AI-led, data-driven capabilities with deep life sciences and supply chain expertise, we enabled a more predictive and resilient supply chain and procurement ecosystem. This approach drives better decision-making at scale, improves access to medicines, and supports sustainable growth in a volatile and regulated environment.”
Positioning for Long-Term Resilience and Growth
Overall, this global supply chain and procurement transformation reinforces Mankind Pharma’s commitment to operational excellence, disciplined execution, and long-term resilience. More importantly, it keeps the company anchored to its core purpose—improving access to quality and affordable medicines.
As healthcare systems evolve and market complexities intensify, the company now stands better equipped to respond with agility, consistency, and scale. In doing so, Mankind Pharma strengthens trust among patients, partners, and stakeholders across India and international markets alike.